Clinical Trials Logo

Acute Diverticulitis clinical trials

View clinical trials related to Acute Diverticulitis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06388538 Not yet recruiting - Clinical trials for Acute Diverticulitis

The COLD2B Multicenter, Two-arm Prospective Cohort Study

COLD2B
Start date: June 1, 2024
Phase:
Study type: Observational

Since it is still debated whether 2b acute diverticulitis (AD), according to the World Society of Emergency Surgery (WSES) classification, should be initially treated surgically or conservatively, the COLD2B study has been launched to compare the clinical results of both therapeutic regimens in a multi-institutional cohort of prospectively enrolled patients. The primary aim of the COLD2B (Conservative vs surgical (either Open or Laparoscopic) approach in the emergency management of acute Diverticulitis WSES 2B) study is to develop a model able to predict the length of hospitalization, comparing the management of WSES 2b AD in the emergency setting (conservative versus surgical approach) (primary endpoint of the first arm of the study). Moreover, the two groups will be compared regarding mortality and morbidity (secondary end-point). The second arm of the study will consider the population undergoing surgery, develop a model able to predict the length of hospitalization, and compare the open vs laparoscopic approach (primary end-point), and mortality, morbidity, and surgical outcome indices (secondary end-point).

NCT ID: NCT01825967 Not yet recruiting - Clinical trials for Acute Diverticulitis

Acute Diverticulitis and C-Reactive Protein as a Prognostic Marker

Start date: April 2013
Phase: N/A
Study type: Observational [Patient Registry]

The management of acute diverticulitis maybe better if we have prognostic markers of evolution. Hypothesis: C-reactive protein maybe a good prognostic marker of evolution of acute diverticulitis. The investigators need to know the values of C-reactive protein to predict evolution of acute diverticulitis.